• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Friday, March 24, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Analyst Corner – Finolex Cables: Reiterate ‘buy’; PT of Rs 600, target PE at 18x

by The Outlooker Web Desk
August 21, 2021
in Business
0
Analyst Corner – Finolex Cables: Reiterate ‘buy’; PT of Rs 600, target PE at 18x
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

We broadly retain FY22-24e EPS. We view FNXC as a SMID Value Pick; FY23e PE at 15x seems undemanding, at discount to peers. Buy; PT at Rs 600.

Key takeaway: FNXC’s Q1FY22 beat JEFe, driven by robust sales growth of +79% YoY. Revenue has been growing at a sturdy pace over past three qtrs, indicating improving offtake. Electrical category is the key catalyst (83% of mix), and could benefit from upswing in housing cycle & capex investments. EBIT margin in appliances stays positive. We broadly retain FY22-24e EPS. We view FNXC as a SMID Value Pick; FY23e PE at 15x seems undemanding, at discount to peers. Buy; PT at Rs 600.

Revenue Traction: FNXC’s Q1FY22 was a beat to JEFe. Earnings growth (+58% YoY) was driven by strong revenue traction of +79%. Sales have been consistently growing at a robust pace over past three quarters. Despite gross margin dip (-290 bps YoY), EBITDA margin expanded by 125 bps to 10.4%, alluding to better operating leverage (higher volumes) and cost control. FNXC mgmt has indicated earlier that a temporary transition from target-based schemes to actual invoices led to higher discount of 8% (vs. 6% earlier) impacting gross margins. This shift is in view of the pandemic and FNXC could likely revert to normal practices, post steady-state resumption.

Electrical Cables: This is FNXC’s mainstay category, with 83% of sales — comprises construction wires (60-65% of mix), auto, agri, and industrial (flexible) cumulative at 25%. Power cables (mainly B2B) is ~10%. In Q1FY22, this segment posted sales growth of +68% YoY, with EBIT margin at 10.8% (+290 bps). In volume terms, Electrical Wires grew by +7%, whereas Power Cables posted +23% growth. Going ahead, we foresee this segment to benefit from an upswing in housing cycle, and capex investments. We estimate Electricals revenue at +12% CAGR over FY21-24.

Communication Cables: This segment posted ~3x revenue growth in Q1, with +240bps expansion in EBIT margin to 2%. While Optic Fiber Cable volumes grew by +290%, volume of metal-based products rose by +71%. Over past few quarters, revenue and margins in this category decelerated, impacted by subdued offtake from telcos, and sharp fall in fibre prices globally. However, over the medium-term, this segment could benefit from 5G roll-out in India, translating into higher demand. We foresee gradual sales revival at +7% CAGR over FY21-24.

New Products / Appliances: This segment is presently < 5% of sales. In Q1, it posted healthy revenue growth of +68%, though EBIT margin dipped to 3.1% (-100 bps), likely impacted by rise in commodities.

Outlook, Value Pick: We slightly tweak FY22-24 EPS, broadly retaining EPS. Over FY21-24e, we pencil FNXC’s sales/PAT at +12%/25% CAGR, aided by improving margin in Electricals, traction in margin-accretive Appliances, new launch (PVC Conduits) and capex commissioning. Note that FY21 was a weak base (EPS dip of 30% YoY). FNXC’s present valuation at 15x/13x PE on FY23/24 appears undemanding, given its strong franchise, focus on margin-accretive Electrical category and a robust B/S. Reiterate ‘buy’; PT of Rs 600 (vs. Rs 590). Retain target PE at 18x, broadly in line with FNXC’s historical 5-year average. We view FNXC as a robust SMID
Value Pick.

Key risks: Demand slowdown, weak traction in new products. A key monitorable is the family tussle within the Finolex group (as reported in the media).

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Uttar Pradesh Police Makes First Arrest Under New Anti-Conversion Law

14 Arrested In Assam Under Anti-Terror Law UAPA For 'Supporting Taliban' On Social Media: Police

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
National

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India

March 24, 2023
Vandalism At Indian High Commission In London Raised In UK Parliament
National

Vandalism At Indian High Commission In London Raised In UK Parliament

March 23, 2023
Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points
National

Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

March 23, 2023
Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation
National

Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation

March 23, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
  • Vandalism At Indian High Commission In London Raised In UK Parliament
  • Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.